Patients with aqueous deficient DED may experience reduced instillation discomfort following cold instillation of cyclosporine A.
Perfluorohexyloctane and lotilaner ophthalmic solution, 2 ocular surface disease drugs, have changed the DED and DB treatment paradigms.